Skip to main content
. 2021 Jan 27;120(3):979–991. doi: 10.1007/s00436-021-07055-5

Table 1.

GST-Specific activity assays of F. hepatica GST samples exposed to TCBZ-SO

Treatment Total activity (nmol/min) Total protein (mg) Specific activity (nmol/min/mg)
Control 4463.44 8.55 522.04 ± 77.92
Sub-lethal 6002.92 10.52 570.62 ± 190.46
Lethal 6190.82 9.35 662.12 ± 134.63

TCBZ-SO at Control (0 μg/ml), sub-lethal (15 μg/ml) or lethal (50 μg/ml) dose. Total activity (nmol/min), total protein (mg) and specific activity (nmol/min/mg) are included